Correspondence 0001193125-26-145150 from AVITA Medical, Inc. (RCEL)
AVITA Medical, Inc.
Date: April 7, 2026 · CIK: 0001762303 · Accession: 0001193125-26-145150
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-294790
Letter
Re:
28159 Avenue Stanford, Suite 220, Valencia, CA 91355
T (833) 462-8482 W AVITAmedical.com
April 7, 2026
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Nicholas O’Leary
AVITA Medical, Inc.
Registration Statement on Form S-3
Filed on March 31, 2026
File No. 333-294790
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), registrant AVITA Medical, Inc. (the “Registrant”) hereby respectfully requests that the above-referenced Registration Statement on Form S-3 be declared effective at 4:30 p.m., Eastern Time, on April 9, 2026 or as soon thereafter as is practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff of the Commission.
Please direct any questions regarding this request to Coleman Wombwell of K&L Gates LLP ((704) 331-7551; coleman.wombwell@klgates.com). In addition, please notify Mr. Wombwell when this request for acceleration has been granted.
Sincerely,
/s/ Nicole Kelsey
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
28159 Avenue Stanford, Suite 220, Valencia, CA 91355
T (833) 462-8482 W AVITAmedical.com
April 7, 2026
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Nicholas O’Leary
Re:
AVITA Medical, Inc.
Registration Statement on Form S-3
Filed on March 31, 2026
File No. 333-294790
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), registrant AVITA Medical, Inc. (the “Registrant”) hereby respectfully requests that the above-referenced Registration Statement on Form S-3 be declared effective at 4:30 p.m., Eastern Time, on April 9, 2026 or as soon thereafter as is practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff of the Commission.
Please direct any questions regarding this request to Coleman Wombwell of K&L Gates LLP ((704) 331-7551; coleman.wombwell@klgates.com). In addition, please notify Mr. Wombwell when this request for acceleration has been granted.
Sincerely,
/s/ Nicole Kelsey
Nicole Kelsey
Chief Legal and Compliance Officer
AVITA Medical, Inc.